Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: A speculative explanation

Neuroscience Research

Volumn 28, Issue 3, 1997, Pages 185-189

  Borlongan, Cesario V ^a   Nishino, Hitoo ^b   Sanberg, Paul R ^c  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

3 nitropropioninc acid; Apoptosis; Excitotoxin; Glutamate receptors; Huntington's disease; Locomotor activity; Necrosis; Neurodegeneration; Striatum; Systemic and intraparenchymal injections

Indexed keywords

3 NITROPROPIONIC ACID; EXCITOTOXIN; NEUROTOXIN;

AKINESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; DYSKINESIA; HUNTINGTON CHOREA; LOCOMOTION; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RAT; RODENT;

ANIMALS; HUNTINGTON DISEASE; INJECTIONS; NEOSTRIATUM; NERVE DEGENERATION; NEUROTOXINS; NITRO COMPOUNDS; PROPIONIC ACIDS; RATS;

EID: 0030928321     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(97)00045-X     Document Type: Article

References (26)

1. Beal, M.F., 1992. Does impairment of energy metabolism result in excitotoxic neruonal death in neruodegnerative illnesses? Ann. Neurol. 31, 119-130.
2. Beal, M.F., Brouillet, E., Jenkins, B., Ferrante, R.J., Kowall, N.W., Miller, J.M., Storey, E., Srivastava, R., Rosen, B.R., Hyman, B.T., 1993. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13, 1481-1492.
3. Borlongan, C.V., Koutouzis, T.K., Freeman, T.B., Cahill, D.W., Sanberg, P.R., 1995. Systemic 3-nitropropionic aicd: behavioral deficits and striatal damage in rats. Brain Res. Bull. 36, 549-556.
4. Borlongan, C.V., Koutouzis, T.K., Freeman, T.B., Cahill, D.W., Sanberg, P.R., 1996a. Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease. Brain Res. 697, 254-257.
5. Borlongan, C.V., Koutouzis, T.K., Poulos, S., Saporta, S., Freeman, T.B., Cahill, D.W., Sanberg, P.R., 1996b. Bilateral fetal striatal transplantation in the 3-nitropropionic acid-induced hypoactive model of Huntington's disease. Soc. Neurosci. Abstr. 22, 580.
6. Borlongan, C.V., Cahill, D.W., Sanberg, P.R., 1996c. Asymmetrical behavior in rats following striatal lesions and fetal transplants: The elevated body swing test. Restor. Neurol. Neurosci. 9, 15-19.
7. Brouillet, E., Jenkins, B.G., Hyman, B.T., Ferrante, R.J., Kowall, N.W., Srivastava, R., Roy, D.S., Rosen, B.R., Beal, M.F., 1993. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60, 356-359.
8. Brouillet, E., Hantraye, P., Ferrante, R.J., Dolan, R., Leroy-Willig, A., Kowall, N.W., Beal, M.F., 1995. Chronic mitochondrial enegy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl. Acad. Sci. 92, 7105-7109.
9. Dong, J., Shear, D.A., Gundy, C.D., Creguer-Haik, K., Dunbar, G.L., 1996. Behavioral and histological comparisons of two animal models of Huntington's disease. Soc. Neurosci. Abstr. 22, 227.
10. Ferrante, R.J., Hantraye, P., Brouillet, E., Kowall, N.W., Beal, M.F., 1993. Striatal pathology of impaired mitochondrial metabolism in primnates profiles Huntington's disease. Soc. Neurosci. Abstr. 19, 408.
11. Galpern, W., Frim, D.M., Matthews, R., Beal, M.F., Isacson, O., 1996. Antioxidative mechanism of NGF-mediated neuroprotection in a 3-NP model of Huntington's disease. Soc. Neurosci. Abstr. 22, 752.
12. Hamilton, B.F., Gould, D.H., 1987. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol (Berl) 72, 286-297.
13. Koutouzis, T.K., Borlongan, C.V., Scorcia, T.A., Sanberg, P.R., 1994a. Systemic 3-nitropropionic acid: long-term effects on locomotor behavior. Brain Res. 646, 242-246.
14. Koutouzis, T.K., Borlongan, C.V., Freeman, T.B., Sanberg, P.R., 1994b. Intrastriatal 3-nitropropionic acid: a behavioral assessment. Neuroreport 5, 2241-2245.
15. Ludolph, A.C., He, F., Spencer, P.S., Hammerstad, J., Sabri, M., 1991. 3-nitropropionic acid - exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18, 492-498.
16. Nakao, N., Brundin, P., 1996. Effects of a-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinic acid and 3-nitropropionic acid. Neuroscience (in press).
17. Nishino, H., Shimano, Y., Kumazaki, M., Sakurai, T., 1995. Chronically administered 3-nitropropionic acid induces striatal lesions attributed to dysfunction of the blood-brain barrier. Neurosci. Lett. 186, 161-164.
18. Nishino, H., Fujimoto, I., Shimano, Y., Hida, H., Kumazaki, M., Fukuda, A., 1996. 3-nitropropionic acid produces striatun selective lesions accompanied by iNOs expression. J. Chem. Neuroanat. 10, 209-212.
19. Nishino, Kumazaki, M., Fukuda, A. Fujimoto, I., Shimano, Y., Hida, H., Sakurai, T., Deshpande, S.B., Shimizu, H., Morikawa, S., Inubushi, T., 1997. Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfucntion of the blood-brain barrier: involvement of dopamine toxicity. Neurosci. Res., 27, 343-355.
20. Palfi, S., Guyot, M.C., Hantraye, P., Altairac, S., Brouileet, E., 1996. Characterization of inhibition of brain succinate dehydrogenase after systemic administration of 3-nitropropionic acid. Soc. Neurosci. Abstr. 22, 1906.
21. Pang, Z., Geddes, J.W., 1996. Mechanisms of cell death induced by mitochondrial toxin 3-nitropropionic acid: concurrent excitotoxity and apoptosis. Soc. Neurosci. Abstr. 22, 1905.
22. Prapurna, R.D., Rountree, R.L., Scallet A.C., Slikker, W., Binienda, Z., 1996. Metabolic effects of 3-nitropropionic acid in the adult rat brain. Soc. Neurosci. Abstr. 22, 1905.
23. Sanberg, P.R., Coyle, J., 1984. Scientific approaches to Huntington's disease. CRC Rev. Clinic. Neurobiol. 1, 1-44.
24. Sanberg, P.R., Wiktorin, K., Isacson, O., 1994. Cell transplantation for Huntington's disease. Medical Intelligence Unit, R.G. Landes, Co., CRC Press, 350 pp.
25. 3 study. Soc. Neurosci. Abstr. 22, 1906.
26. Shimano, Y., Kumazaki, M., Sakurai, T., Hida, H., Fujimoto, I., Fukuda, A., Nishino, H., 1995. Chronically administered 3-nitropropionic acid produces selective striatal lesions in striatum and reduces muscle tonus. Obesity Res. 3, 779-784.